Please login to the form below

Not currently logged in
Email:
Password:

V114

This page shows the latest V114 news and features for those working in and with pharma, biotech and healthcare.

Merck wins speedy FDA review for 15-valent pneumococcal vaccine

Merck wins speedy FDA review for 15-valent pneumococcal vaccine

Merck &Co (MSD) has been given a fast-track designation for its next-generation 15-valent pneumococcal conjugate vaccine candidate V114. ... In September, Merck announced the top-line results from two phase 3 studies evaluating the safety and

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...